Gregory Martens

Medicine & Life Sciences

1. Swine 100%
2. swine leukocyte antigen 69%
3. Heterophile Antigens 54%
4. Heterologous Transplantation 46%
5. Antibodies 31%
6. Transplants 24%
7. Kidney 22%
8. Epitopes 18%
9. Immunosuppression 16%
10. CMPacetylneuraminate monooxygenase 16%
11. Gene Editing 15%
12. Genetic Engineering 15%
13. Primates 15%
14. Polysaccharides 14%
15. Heterografts 14%
16. Cytidine Monophosphate N-Acetylneuraminic Acid 14%
17. CRISPR-Associated Protein 9 13%
18. Blood Platelets 11%
19. Gene Silencing 11%
20. Genes 11%
21. Macaca mulatta 11%
22. Tissue Donors 10%
23. Histocompatibility 10%
24. T-Lymphocytes 10%
25. Robotics 9%
26. Histocompatibility Testing 9%
27. HLA Antigens 9%
28. Mutagenesis 9%
29. Antigens 9%
30. Clustered Regularly Interspaced Short Palindromic Repeats 9%
31. Pancreaticoduodenectomy 8%
32. Psychology Rejection 8%
33. Glycosyltransferases 8%
34. Homologous Recombination 8%
35. Living Donors 8%
36. Transgenes 8%
37. Operating Rooms 7%
38. Nephrectomy 7%
39. Heterophile Antibodies 6%
40. Endothelium 6%
41. Teaching 6%
42. Peptic Ulcer 6%
43. Guide RNA 6%
44. Immunoglobulin G 6%
45. Surgeons 5%
46. Serum 5%
47. Meta-Analysis 5%
48. Immunoglobulin M 5%